Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Synergy Pharmaceuticals, Inc.
New York, New York
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our reports dated March 16, 2011, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting of Synergy Pharmaceuticals, Inc. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP |
New York, New York |
|
November 3, 2011 |
